This Day On The Street
Continue to site right-arrow
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
Stocks Under $10 with 50-100% upside potential - 14 days FREE!

Aegerion Pharmaceuticals Inc (AEGR)

NASDAQ: Health Care

Company Balance Sheet
Dec 2013 Dec 2012 Dec 2011 Dec 2010
Assets
Cash and Equivalents 61.01M 37.17M 26.37M 44.10M
Receivables 7.57M 0.00 0.00 0.00
Inventories 1.64M 0.00 0.00 0.00
Other Current Assets 0.00 0.00 0.00 0.00
Total Current Assets 140.51M 83.75M 74.08M 44.61M
Property, Plant & Equipment, Gross 2.40M 1.42M 623.31K 93.60K
Accumulated Depreciation & Depletion 745.00K 276.00K 96.96K 77.12K
Property, Plant & Equipment, Net 1.65M 1.14M 526.35K 16.47K
Intangibles 0.00 0.00 0.00 0.00
Other Non-Current Assets 164.00K 198.00K 965.19K 1.12M
Total Non-Current Assets 1.82M 1.34M 1.49M 1.14M
Liabilities & Shareholder Equity
Total Assets 142.33M 85.09M 75.57M 45.75M
Accounts Payable 4.14M 4.95M 2.80M 3.15M
Short Term Debt 3.58M 3.02M 1.88M 0.00
Other Current Liabilities 0.00 0.00 164.14K 1.03M
Total Current Liabilities 24.84M 16.93M 9.40M 4.67M
Long Term Debt 4.01M 7.59M 8.12M 0.00
Deferred Income Taxes 0.00 0.00 0.00 0.00
Other Non-Current Liabilities 445.00K 173.00K 841.43K 0.00
Minority Interest 0.00 0.00 0.00 0.00
Total Non-Current Liabilities 4.46M 7.76M 8.97M 0.00
Total Liabilities 29.30M 24.69M 18.37M 4.67M
Preferred Stock Equity 0.00 0.00 0.00 0.00
Common Stock Equity 113.03M 60.40M 57.20M 41.08M
Common Par 29.00K 25.00K 21.30K 17.74K
Additional Paid In Capital 369.06M 253.21M 187.69M 131.55M
Cumulative Translation Adjustment 0.00 0.00 0.00 0.00
Retained Earnings -256.08M -192.72M -130.46M -90.99M
Treasury Stock 0.00 0.00 -373.00 -373.00
Other Equity Adjustments 28.00K -112.00K -48.00K 500.02K
Total Capitalization 117.04M 67.99M 65.33M 41.08M
Total Equity 113.03M 60.40M 57.20M 41.08M
Total Liabilities & Stock Equity 142.33M 85.09M 75.57M 45.75M
Total Common Shares Outstanding 29.38M 25.49M 21.20M 17.64M
Preferred Shares 0.00 0.00 0.00 0.00
Treasury Shares 104.00K 104.00K 103.76K 103.76K
Basic Weighted Shares Outstanding 28.88M 23.56M 19.41M 11.08M
Diluted Weighted Shares Outstanding 28.88M 23.56M 19.41M 11.08M
Number of Employees 217 98 33 16
Number of Part-Time Employees 0 0 0 0
AEGR News

AEGR Aegerion Pharmaceuticals Inc

Analysts Ratings for AEGR

Rating Current 1-Mo Ago 2-Mo Ago 3-Mo Ago
Strong Buy 2 2 7 7
Moderate Buy 0 0 0 0
Hold 5 5 1 1
Moderate Sell 1 1 0 0
Strong Sell 0 0 0 0
GET AEGR ANALYST REPORT

Brokerage Partners

AEGR Chatter

Select the service that is right for you!

COMPARE ALL SERVICES
Action Alerts PLUS

Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
Real Money Pro

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass Plus 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Trifecta Stocks

Trifecta Stocks analyzes over 4,000 equities weekly to find the elite 1% of stocks that pass rigorous quantitative, fundamental and technical tests.

Product Features:
  • Model portfolio
  • Trade alerts
  • Recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
Stocks Under $10

David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
  • Upgrade/downgrade alerts
Dividend Stock Advisor

Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Breakout Stocks

Bryan Ashenberg, using sophisticated stock screening and fundamental research, identifies potentially explosive small and mid-cap stocks.

Product Features:
  • Model portfolio
  • Small-cap and mid-cap focus
  • Intraday trade alerts
  • Weekly roundups
Options Profits

Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • 100+ monthly options trading ideas
  • Actionable options commentary & news
  • Real-time trading community
  • Options TV
Top Rated Stocks Top Rated Funds Top Rated ETFs